SEC Form 4 · accession 0001144204-18-032122
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Joseph McGorry
Officer — Chief Executive Officer · Director
Period of report
May 29, 2018
Accepted (ET)
May 31, 2018 · 8:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.72 | May 29, 2018 | A | 171,233 | A | — | May 29, 2028 | Common Stock, par value $0.01 per share | 171,233 | 171,233 | D |
| Stock Option (right to buy)F2 | $2.72 | May 29, 2018 | A | 171,234 | A | — | May 29, 2028 | Common Stock, par value $0.01 per share | 171,234 | 171,234 | D |
Explanation of responses
- F1Non-Qualified Stock Option shares that vest based on certain performance milestones.
- F2Stock Option shares that vest in four equal installments on December 31, 2018, 2019, 2020 and 2021 (of the shares underlying this stock option grant, 147,056 shares are incentive stock options and 24,178 are non-qualified stock options).
Remarks
This form has been signed under power of attorney.